Which companies discussed GLP-1 Drugs in Health Care in earnings calls?

345 companies mentioned glp-1 drugs across 935 earnings calls in Health Care over the past year, spanning 1 sectors. The most active were West Pharmaceutical Services, Inc. (14 calls), Novo Nordisk A/S (12 calls), Zealand Pharma A/S (11 calls). The table below ranks every company by how often the theme came up, with direct links to each transcript.

Mentions over time

Data table
QuarterCalls mentioning GLP-1 Drugs
2024Q375
2024Q4204
2025Q1235
2025Q2144
2025Q3203
2025Q4226
2026Q1274
2026Q2236
2026Q3107

Companies ranked by mentions

Company Ticker Sector Calls Last mention
West Pharmaceutical Services, Inc. WST Health Care 14 Jul 23, 2026
Novo Nordisk A/S NOVOB Health Care 12 Aug 5, 2026
Zealand Pharma A/S ZEAL Health Care 11 Aug 13, 2026
McKesson Corporation MCK Health Care 11 Aug 5, 2026
Cencora, Inc. COR Health Care 11 Aug 5, 2026
Pfizer Inc. PFE Health Care 11 Aug 4, 2026
Rhythm Pharmaceuticals, Inc. RYTM Health Care 11 Aug 4, 2026
Altimmune, Inc. ALT Health Care 10 Aug 12, 2026
Wave Life Sciences Ltd. WVE Health Care 10 Aug 11, 2026
Eli Lilly and Company LLY Health Care 10 Aug 5, 2026
Inspire Medical Systems, Inc. INSP Health Care 10 Aug 3, 2026
Viking Therapeutics, Inc. VKTX Health Care 10 Jul 29, 2026
Cardinal Health, Inc. CAH Health Care 9 Aug 11, 2026
Madrigal Pharmaceuticals, Inc. MDGL Health Care 9 Aug 11, 2026
Amylyx Pharmaceuticals, Inc. AMLX Health Care 9 Aug 6, 2026
Waters Corporation WAT Health Care 9 Aug 4, 2026
Amgen Inc. AMGN Health Care 9 Aug 4, 2026
Arrowhead Pharmaceuticals, Inc. ARWR Health Care 9 Jun 10, 2026
Fractyl Health, Inc. GUTS Health Care 8 Aug 10, 2026
Mettler-Toledo International Inc. MTD Health Care 8 Jul 31, 2026
Agilent Technologies, Inc. A Health Care 8 May 27, 2026
Omada Health, Inc. OMDA Health Care 7 Aug 6, 2026
ResMed Inc. RMD Health Care 7 Aug 6, 2026
Becton, Dickinson and Company BDX Health Care 7 Aug 6, 2026
Stevanato Group S.p.A. STVN Health Care 7 Aug 4, 2026
Amneal Pharmaceuticals, Inc. AMRX Health Care 7 Jul 30, 2026
Sana Biotechnology, Inc. SANA Health Care 7 Jun 9, 2026
Revvity, Inc. RVTY Health Care 7 Jun 9, 2026
Embecta Corp. EMBC Health Care 6 Aug 7, 2026
Biocon Limited BIOCON Health Care 6 Aug 6, 2026
Merck & Co., Inc. MRK Health Care 6 Aug 4, 2026
Haleon plc HLN Health Care 6 Jul 30, 2026
Regeneron Pharmaceuticals, Inc. REGN Health Care 6 Jul 30, 2026
The Cigna Group CI Health Care 6 Jul 30, 2026
Elanco Animal Health Incorporated ELAN Health Care 6 Jun 2, 2026
Amphastar Pharmaceuticals, Inc. AMPH Health Care 6 May 13, 2026
Biomea Fusion, Inc. BMEA Health Care 6 May 5, 2026
Apyx Medical Corporation APYX Health Care 5 Aug 6, 2026
GoodRx Holdings, Inc. GDRX Health Care 5 Aug 6, 2026
Insulet Corporation PODD Health Care 5 Aug 5, 2026
Sandoz Group AG SDZ Health Care 5 Aug 5, 2026
Vanda Pharmaceuticals Inc. VNDA Health Care 5 Aug 5, 2026
AstraZeneca PLC AZN Health Care 5 Jul 27, 2026
Roche Holding AG ROG Health Care 5 Jul 23, 2026
Orexo AB (publ) ORX Health Care 5 Jul 16, 2026
Absci Corporation ABSI Health Care 5 Jun 3, 2026
HealthEquity, Inc. HQY Health Care 5 May 28, 2026
DaVita Inc. DVA Health Care 5 May 12, 2026
Skye Bioscience, Inc. SKYE Health Care 5 Mar 10, 2026
Biogen Inc. BIIB Health Care 5 Mar 2, 2026

Representative quotes

…more benign one can deliver the weight loss most patients are actually after. For the patients with higher BMI and/or complications at GLP-1 with established evidence or higher efficacy dual or triple agonist could be the option. Then if those paths fell short of the patient…
Zealand Pharma A/S (ZEAL), August 13, 2026. Read the full transcript →
…total revenue. At the same time, we continue to maintain a diversified pipeline of active custom projects with strong exposure to metabolics, including GLP-1 receptor agonists as well as oncology and neurology. That diversity underpins the quality and resilience of our growth. So in short, large programs…
PolyPeptide Group AG (PPGN), August 13, 2026. Read the full transcript →
…very highly managed category, in terms of rosacea and kind of what the payers have on their plates. When you think of GLP-1s, other oncology, rare disease, orphan drugs. So it takes a little bit more time. We are having, again, we have great contacts with…
Journey Medical Corporation (DERM), August 12, 2026. Read the full transcript →
…highly managed category, right, in terms of rosacea and kind of what the payers have on their plates, right, when you think of GLP-1s, other oncology, rare disease orphan drugs. So it takes a little bit more time. We are having -- again, we have great contacts with…
Fortress Biotech, Inc. (FBIO), August 12, 2026. Read the full transcript →

Frequently asked questions

What is GLP-1 Drugs and why are companies discussing it?

Weight-loss and diabetes drugs (Wegovy, Mounjaro, Zepbound) reshaping consumer demand, retail pharmacy economics and bioprocess equipment orders.

Which company mentioned glp-1 drugs most in Health Care in the past year?

West Pharmaceutical Services, Inc. (WST) led with 14 calls referencing glp-1 drugs, most recently on July 23, 2026.

How can I track glp-1 drugs mentions across earnings calls via API?

The EarningsCalls.dev REST API exposes the same data behind this page. Use the search_transcripts and count_mentions_by_ticker endpoints to query our archive of 33,000+ earnings call transcripts — keyword search, sector / date filters, per-company mention counts, and the underlying full transcripts. See the API docs →

Related healthcare themes

Last updated: August 14, 2026. Methodology: full-text search across all earnings call transcripts in our corpus over the past 12 months, matching the canonical term and its aliases (GLP, glp-1, glp1, glp 1). Mentions are per call, not per occurrence within a call; the company-rank table is built by counting distinct calls mentioning the theme. Page refreshes every hour at the edge as new calls land in our archive.